Skip to main content

Table 1 Description of active malaria grants, stratified by grant-making organization

From: Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries

 

PMI, N = 39, N (%)

Global Fund N = 107, N (%)

World Bank N = 13, N (%)

Total, N = 159, N (%)

WHO Region

 Americas

0 (0)

8 (7.5)

0 (0)

8 (5.0)

 Africa

37 (94.9)

64

11

 

 Eastern Mediterranean

0 (0)

1 (0.9)

1 (7.7)

2 (1.3)

 East Asia and Pacific

2 (5.1)

16 (15.0)

1 (7.7)

19 (12.0)

 South Asia

0 (0)

13 (12.2)

0 (0)

13 (8.2)

 Europe

0 (0)

5 (4.7)

0 (0)

5 (3.1)

World Bank income group

 Upper-middle income

4 (10.3)

8 (7.5)

0 (0)

12 (7.6%)

 Lower-middle income

8 (20.5)

45 (42.1)

3 (23.1)

56 (35.2%)

 Low income

27 (69.2)

54 (50.5)

10 (76.9)

91 (57.2%)

Amount of granta

12.7 million USD (3–70 million USD)

30.0 million USD (0.6–284 million USD)

82.0 million USD (46–500 million USD)

33.3 million USD (0.6–500 million USD)

Pharmacovigilance mentions

 Grant mentions pharmacovigilance

21 (53.9)

2 (1.9)

0 (0)

23 (14.5)

 Grant provides budget line for pharmacovigilance

21 (53.9)

16 (15.0)

0 (0)

37 (23.3)

  1. aDenotes a mean and range